Manufacturing Pharmaceutical Promotion 
Office Snapshots
FEBRUARY 22, 2024
for life science research and manufacturing because it is culturally diverse and is home to a multitude of diverse ways of thinking. The result: people-centric, diverse amenities that connect and promote collaboration. There is an attraction to L.A.
Mad in America
FEBRUARY 14, 2024
From The Guardian : “In 2017, the Cherokee Nation became the first tribe to file a lawsuit against opioid manufacturers and distributors for promoting the flow of prescription opioids into its community.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Office Snapshots
MARCH 12, 2024
Sheldon’s workplace design for global pharmaceuticals company Novo Nordisk breaks conventional workplace norms by separating two floors into a collaboration floor and a focus floor, catering to neurodiverse needs. This helps promote users’ Circadian rhythms.
Mad in America
OCTOBER 28, 2023
However, in the summer of 1990, the Prozac story started to come undone, and it was then that the pharmaceutical industry, in concert with its thought leaders from academic psychiatry, plotted the strategy that has successfully cowed the mainstream media ever since.
Mad in America
OCTOBER 18, 2023
For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.
Mad in America
SEPTEMBER 7, 2024
Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.
Mad in America
OCTOBER 30, 2023
There was no placebo group, and all patients started on citalopram, manufactured by Lundbeck, which was motivated by horrendously erroneous claims of citalopram’s “absence of discontinuation symptoms” and its “safety” in elderly patients. Nothing in Insel’s narrative would harm psychiatry’s guild interests or pharmaceutical interests.
Expert insights. Personalized for you.
98 
Let's personalize your content